ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.6551
-0.0591 (-8.27%)
At close: Mar 28, 2025, 4:00 PM
0.6777
+0.0226 (3.45%)
Pre-market: Mar 31, 2025, 4:18 AM EDT
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $34.97 million as of March 28, 2025. Its market cap has decreased by -93.99% in one year.
Market Cap
34.97M
Enterprise Value
-75.81M
1-Year Change
-93.99%
Ranking
Category
Stock Price
$0.66
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $34.97M, a decrease of -96.69%. That is a compound annual growth rate of -51.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 34.97M | -60.30% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | 3.43B | 225.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |